Keyword

DC101

Description: DC101 is a monoclonal antibody used experimentally to block VEGFR2 and inhibit angiogenesis in biomedical research.
OpenAlex ID: keywords/dc101
2000 · Giannoula Klement, Sylvain Baruchel, et al. · Journal of Clinical Investigation · 1,252
2005 · Jianmin Fang, Jing-Jing Qian, et al. · Nature Biotechnology · 406
1998 · Larry Witte, Daniel J. Hicklin, et al. · Cancer and Metastasis Reviews · 326
2013 · Lotfi Abou-Elkacem, Susanne Arns, et al. · Molecular Cancer Therapeutics · 296
2007 · Elizabeth A. Manning, John G.M. Ullman, et al. · Clinical Cancer Research · 216
2012 · Federica Maione, Stefania Capano, et al. · Journal of Clinical Investigation · 197
2016 · Beverly L. Falcon, Sudhakar Chintharlapalli, et al. · Pharmacology & Therapeutics · 149
2013 · Neil R. Smith, Dawn Baker, et al. · Clinical Cancer Research · 148
2015 · Han-Sin Jeong, Dennis Jones, et al. · JNCI Journal of the National Cancer Institute · 130
Works count: 225
Citation count: 12,010
Year
Topic
Type